Walleye Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Buy
3,400
+2,100
+162% +$186K ﹤0.01% 3028
2025
Q4
$104K Sell
1,300
-1,500
-54% -$126K ﹤0.01% 3849
2025
Q3
$273K Sell
2,800
-7,400
-73% -$596K ﹤0.01% 3090
2025
Q2
$711K Buy
+10,200
New +$582K ﹤0.01% 2334
2025
Q1
Sell
-1,100
Closed -$76.9K 4163
2024
Q4
$76.9K Sell
1,100
-1,200
-52% -$99.7K ﹤0.01% 4234
2024
Q3
$241K Sell
2,300
-14,900
-87% -$1.74M ﹤0.01% 3859
2024
Q2
$2.45M Buy
17,200
+1,100
+7% +$127K ﹤0.01% 1916
2024
Q1
$1.8M Buy
16,100
+4,100
+34% +$489K ﹤0.01% 2072
2023
Q4
$1.56M Buy
12,000
+6,800
+131% +$937K ﹤0.01% 1984
2023
Q3
$848K Sell
5,200
-7,800
-60% -$1.37M ﹤0.01% 2388
2023
Q2
$2.38M Buy
13,000
+4,200
+48% +$605K 0.01% 1214
2023
Q1
$1.17M Buy
+8,800
New +$1.03M 0.02% 1050

Other funds holding ACLS

Walleye Capital's ACLS Position: Q1 2026 in Review

Walleye Capital sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 108 shares — an estimated $9.56K sold.

Walleye Capital first reported a position in ACLS in Q2 2022 and held it in 9 quarters. The position peaked at $4.68M in Q1 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Walleye Capital reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 108 Axcelis shares in Q1 2026, an estimated $9.56K.
  • Walleye Capital first reported a position in Axcelis in Q2 2022 and held it in 9 quarters.
  • Walleye Capital's Axcelis position peaked at $4.68M in Q1 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.